Anti-FBLN1/ FBLN/ FIBL1 functional antibody

Anti-FBLN1/ FBLN/ FIBL1 functional antibody for cell culture, ELISA & in-vivo assay

Target products collectionGo to FBLN1/FBLN1 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-SE0913-Ab-1/ GM-Tg-hg-SE0913-Ab-2Anti-Human FBLN1 monoclonal antibodyHuman
GM-Tg-rg-SE0913-Ab-1/ GM-Tg-rg-SE0913-Ab-2Anti-Rat FBLN1 monoclonal antibodyRat
GM-Tg-mg-SE0913-Ab-1/ GM-Tg-mg-SE0913-Ab-2Anti-Mouse FBLN1 monoclonal antibodyMouse
GM-Tg-cynog-SE0913-Ab-1/ GM-Tg-cynog-SE0913-Ab-2Anti-Cynomolgus/ Rhesus macaque FBLN1 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-SE0913-Ab-1/ GM-Tg-felg-SE0913-Ab-2Anti-Feline FBLN1 monoclonal antibodyFeline
GM-Tg-cang-SE0913-Ab-1/ GM-Tg-cang-SE0913-Ab-2Anti-Canine FBLN1 monoclonal antibodyCanine
GM-Tg-bovg-SE0913-Ab-1/ GM-Tg-bovg-SE0913-Ab-2Anti-Bovine FBLN1 monoclonal antibodyBovine
GM-Tg-equg-SE0913-Ab-1/ GM-Tg-equg-SE0913-Ab-2Anti-Equine FBLN1 monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-SE0913-Ab-1/ GM-Tg-hg-SE0913-Ab-2; GM-Tg-rg-SE0913-Ab-1/ GM-Tg-rg-SE0913-Ab-2;
GM-Tg-mg-SE0913-Ab-1/ GM-Tg-mg-SE0913-Ab-2; GM-Tg-cynog-SE0913-Ab-1/ GM-Tg-cynog-SE0913-Ab-2;
GM-Tg-felg-SE0913-Ab-1/ GM-Tg-felg-SE0913-Ab-2; GM-Tg-cang-SE0913-Ab-1/ GM-Tg-cang-SE0913-Ab-2;
GM-Tg-bovg-SE0913-Ab-1/ GM-Tg-bovg-SE0913-Ab-2; GM-Tg-equg-SE0913-Ab-1/ GM-Tg-equg-SE0913-Ab-2
Products NameAnti-FBLN1 monoclonal antibody
Formatmab
Target NameFBLN1
Protein Sub-locationSecreted Protein/Potential Cytokines
Category of antibodyFACS/Biofunctional Antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The biofunction of antibodies are validated with in-vitro assay (IC50 or EC50 TBD).
TagFc
Products descriptionPre-made anti-FBLN1 benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-SE0913-Ag-1Recombinant multi-species FBLN1/ FBLN/ FIBL1 protein


    Target information

    Target IDGM-SE0913
    Target NameFBLN1
    Gene ID2192,14114,315191,713606,474468,101089120,514588,100052767
    Gene Symbol and SynonymsFBLN,FBLN1,FIBL1
    Uniprot AccessionP23142
    Uniprot Entry NameFBLN1_HUMAN
    Protein Sub-locationSecreted Protein/Potential Cytokines
    Category
    DiseaseProstate Cancer
    Gene EnsemblENSG00000077942
    Target ClassificationN/A

    The target: FBLN1, gene name: FBLN1, also named as FBLN, FIBL1. Fibulin 1 is a secreted glycoprotein that becomes incorporated into a fibrillar extracellular matrix. Calcium-binding is apparently required to mediate its binding to laminin and nidogen. It mediates platelet adhesion via binding fibrinogen. Four splice variants which differ in the 3' end have been identified. Each variant encodes a different isoform, but no functional distinctions have been identified among the four variants. [provided by RefSeq, Jul 2008].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.